Revance Therapeutics | RVNC - Employees Total Number


Revance Therapeutics reported 534 in Employees for its fiscal year ending in December of 2022.



Employees Change Date
AbbVie 55K 5K Dec/2024
ALKERMES 1.8K 300 Dec/2024
Bristol-Myers Squibb 34.1K 0 Dec/2024
Cara Therapeutics 55 51 Dec/2023
Coherus Biosciences 306 53 Dec/2023
Eli Lilly 47K 4K Dec/2024
J&J 138.1K 6.2K Dec/2024
Merck 75K 3K Dec/2024
Neurocrine Biosciences 1.8K 400 Dec/2024
P&G 109K 1000 Dec/2025
Pacira 790 79 Dec/2024
Supernus Pharmaceuticals 674 22 Dec/2024